Skip Navigation

Cardiovascular Research 2001 50(2):345-353; doi:10.1016/S0008-6363(01)00259-0
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hondeghem, L. M
Right arrow Articles by De Clerck, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hondeghem, L. M
Right arrow Articles by De Clerck, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia

Luc M Hondeghema,*, Karl Dujardinb and Fred De Clerckc

aDepartment of Pharmacology, K.U.L., Leuven B-3000, Belgium
bDepartment of Cardiology, H. Hart Ziekenhuis, 8800 Roeselare, Belgium
cDepartment of Cardiovascular Safety Pharmacology, Janssen Research Foundation, B-2340 Beerse, Belgium

* Corresponding author. Present address: H.P.C. nv, Westlaan 85, B-8400 Oostende, Belgium. Tel.: +32-59-510-047; fax: +32-59-510-048 luchondeghem{at}yahoo.com

Objective: To evaluate whether prolongation of the plateau of the action potential duration, in the absence of instability and triangulation, can reverse the proarrhythmia elicited by a class III antiarrhythmic agent. Methods: The effects of almokalant, erythromycin and their combination, on cardiac electrophysiological parameters (action potential duration (APD), instability, triangulation and ectopics) were evaluated in isolated hearts from female albino rabbits. In this study, proarrhythmia was estimated quantitatively by number of ectopic beats. Results: Erythromycin lengthened the APD primarily by a prolongation of the plateau, while having only minor effects upon phase 3 repolarization. The prolongation did not induce much instability, triangulation or reverse use dependence and, as expected, erythromycin did not induce significant proarrhythmia. Almokalant also lengthened APD, but it did not lengthen the plateau; instead, it prolonged phase 3 repolarization. The prolongation markedly triangulated the action potential, elicited much instability and marked reverse use dependence. This combination of effects induced very marked proarrhythmia. When almokalant and erythromycin were combined, their effects upon APD appeared additive: both the plateau and the repolarization phase were prolonged. However, the larger prolongation of APD did not lead to more proarrhythmia; this suggests that a prolongation of APD is not proarrhythmic per se. On the contrary, proarrhythmia as a function of APD prolongation was reduced in the presence of erythromycin (P<0.05). Conclusion: Instability plus triangulation consistently lead to serious proarrhythmia especially when combined with reverse use dependence, but prolongation of APD in itself is not necessarily proarrhythmic. In fact, APD prolongation in the absence of instability and triangulation can be antiarrhythmic.

KEYWORDS APD, action potential duration; APDx, APD to x% repolarization, e.g. APD60 is the APD to 60% repolarization; EAD, early afterdepolarization; TdP, torsade de pointes; Triangulation, difference between APD30 and APD90 prolongation, the action potential assumes a more triangular shape. The APD0 to APD30 is used as a quantitative index of the plateau or phase 2, while the APD30 to APD90 is used as a quantitative index of phase 3.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
M. B. Thomsen, S. C. Verduyn, M. Stengl, J. D.M. Beekman, G. de Pater, J. van Opstal, P. G.A. Volders, and M. A. Vos
Increased Short-Term Variability of Repolarization Predicts d-Sotalol-Induced Torsades de Pointes in Dogs
Circulation, October 19, 2004; 110(16): 2453 - 2459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Cherry and F. H. Fenton
Suppression of alternans and conduction blocks despite steep APD restitution: electrotonic, memory, and conduction velocity restitution effects
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2332 - H2341.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. C. Sanguinetti and P. B. Bennett
Antiarrhythmic Drug Target Choices and Screening
Circ. Res., September 19, 2003; 93(6): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. M Spooner, S. G Priori, and R. J Myerburg
Spotlight on sudden cardiac death
Cardiovasc Res, May 1, 2001; 50(2): 173 - 176.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.